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Safe trade of healthy, vaccinated animals
WP 4.3 DIVA diagnostics
The work performed in WP 4.3 is used to improve the 
diagnostics in general. Diagnostics includes virus 
detection early after infection(Genetic DIVA) and 
diagnostic based on the specific antibodies (see 
figure above where BRSV is used as example).
Genetic DIVA: Genetic differentiation of infected from 
BRSV Calf IV.10
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vaccinated animals is an important new strategy for disease 
control. As C-strain is used worldwide DIVA diagnostics 
differentiating C-strain vaccinated animals would be a large 
step ahead. A real-time reverse transcription polymerase 
chain reaction (RT-PCR) protocol for differentiation of C-
strain “Riems” vaccine virus from CSF virus (CSFV) field 
isolates was published.
Genetic DIVA has been used to differentiate CSFV infection 
in wild boar in areas where prophylactic live bait vaccination 
was used.
Serological DIVA diagnostics:
BTV DIVA diagnostics: The first results obtained indicate 
that BTV-inactivated vaccines used in the field are not free 
of NS 2 and 3 proteins. A better purification of these 
vaccines is necessary to develop this kind of DIVA strategy. 
NS1 antibodies are not always present after infection.
CSFV DIVA diagnostics: For the evaluation of CSFV 
Antibody ELISAs seven commercially available test kits from 
seven providers were tested in five CSF reference 
laboratories. A manuscript was submitted for publication. 
New expression systems are being tried for production of 
antigens for serological tests. 
FMDV DIVA diagnostis: A considerable amount of work 
has been spent to stabilise the home-made ELISA for the 
detection of antibodies to FMDV NSP test (called 3ABC-
trapping ELISA) developed at IZSLER. This work led to the 
availability of a ready-to-use, stable kit, then usable also in 
poorly equipped laboratories.
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